tiprankstipranks
Oncolytics Biotech (ONCY)
NASDAQ:ONCY
US Market

Oncolytics Biotech (ONCY) Technical Analysis

Compare
1,234 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
6Neutral
12Bearish
Technical Analysis Consensus
Sell
1Bullish
6Neutral
3Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
Oncolytics Biotech’s (ONCY) Moving Averages Convergence Divergence (MACD) indicator is -0.03, suggesting Oncolytics Biotech is a Sell.
Oncolytics Biotech’s (ONCY) 20-Day exponential moving average is 0.65, while Oncolytics Biotech’s (ONCY) share price is $0.63, making it a Sell.
Oncolytics Biotech’s (ONCY) 50-Day exponential moving average is 0.72, while Oncolytics Biotech’s (ONCY) share price is $0.63, making it a Sell.

Oncolytics Biotech (ONCY) Pivot Points

Mar 27, 2025, 10:23 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.59
0.60
0.62
0.63
0.65
0.66
0.68
Fibonacci
0.60
0.62
0.62
0.63
0.64
0.65
0.66
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Oncolytics Biotech (ONCY) Moving Averages

Mar 27, 2025, 10:23 AM
Period
Simple
Exponential
MA5
0.63Buy
0.63Buy
MA10
0.62Buy
0.63Sell
MA20
0.65Sell
0.65Sell
MA50
0.72Sell
0.72Sell
MA100
0.84Sell
0.81Sell
MA200
0.94Sell
0.91Sell
Oncolytics Biotech’s (ONCY) 10-Day exponential moving average is 0.63, while Oncolytics Biotech’s (ONCY) share price is $0.63, making it a Sell.
Oncolytics Biotech’s (ONCY) 100-Day exponential moving average is 0.81, while Oncolytics Biotech’s (ONCY) share price is $0.63, making it a Sell.
Oncolytics Biotech’s (ONCY) stock price is $0.63 and Oncolytics Biotech’s (ONCY) 50-day simple moving average is 0.72, creating a Sell signal.
Oncolytics Biotech’s (ONCY) stock price is $0.63 and Oncolytics Biotech’s (ONCY) 100-day simple moving average is 0.84, creating a Sell signal.
Oncolytics Biotech’s (ONCY) stock price is $0.63 and Oncolytics Biotech’s (ONCY) 200-day simple moving average is 0.94, creating a Sell signal.

Oncolytics Biotech (ONCY) Technical Indicators

Mar 27, 2025, 10:23 AM
Name
Value
Implied Action
RSI (14)
39.72
Neutral
STOCH (9,6)
64.15
Neutral
STOCHRSI (14)
27.32
Neutral
MACD (12,26)
-0.03
Sell
ADX (14)
20.45
Neutral
Williams %R
-72.68
Buy
CCI (14)
-40.27
Neutral
ATR (14)
0.04
-
Ultimate Oscillator
43.79
Neutral
ROC
-14.86
Sell
Oncolytics Biotech’s (ONCY) Relative Strength Index (RSI) is 39.72, creating a Neutral signal.
Oncolytics Biotech’s (ONCY) Trend Strength Indicator (ADX) is 20.45, creating a Neutral signal.
Oncolytics Biotech’s (ONCY) Commodity Channel Index (CCI) is -40.27, creating a Neutral signal.
Oncolytics Biotech’s (ONCY) Price Rate of Change (ROC) is -14.86, creating a Sell signal.

FAQ

Is ONCY a Buy, Hold, or Sell?
Based on ONCY’s technical indicators, ONCY is a Sell.
    What is ONCY’s RSI (14)?
    ONCY’s RSI (14) is 39.72, which suggests ONCY is a Neutral.
      What is ONCY’s MACD?
      ONCY’s MACD is -0.03, which suggests ONCY is a Sell.
        What is ONCY’s 5-day moving average?
        ONCY’s 5-day moving average is 0.63, which suggests ONCY is a Buy.
          What is ONCY’s 20-day moving average?
          ONCY 20-day moving average is 0.65, which suggests ONCY is a Sell.
            What is ONCY’s 50-day moving average?
            ONCY’s 50-day moving average is 0.72, which suggests ONCY is a Sell.
              What is ONCY’s 200-day moving average?
              ONCY’s 200-day moving average is 0.94, which suggests ONCY is a Sell.
                What is ONCY’s Williams % R (14)?
                ONCY’s Williams % R (14) is -72.68, which suggests ONCY is a Buy.
                  What is ONCY’s CCI (14)?
                  ONCY’s CCI (14) is -40.27, which suggests ONCY is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis